EXOMAS EXO Kit
Prepares autologous platelet derived exosome rich plasma from the patient's own blood.
Applications
Skin rejuvenation.- Hair restoration.
- Wrinkle treatment, scar management and hyperpigmentation disorders in dermatology.
- Follicular thickening, increased hair density and growth stimulation for weakened hair follicles, frequently applied following hair transplantation.
How it works
EXOMAS is designed to stimulate platelets and trace blood cells within PRP to release extracellular vesicles, through a proprietary protocol and processing system that yields a plasma enriched with platelet-derived exosomes. A Cellitium 600 micron blade in the kit induces controlled shear stress on blood cells to promote that release and plays a role in platelet activation, and the kit's patented D-MED Next-Generation PRX Tube, with its own proprietary internal architecture, supports platelet activation and sediments trace blood cells to the tube's bottom layer.
Vesicle yield
About 1.5 trillion vesicles per mL, using D-MED's Prime Protocol
Final product volume
About 8 to 10 cc
Total per preparation
About 12 trillion vesicles on average
Average vesicle size
127.9 nm, as measured in studies
Platelet-derived exosome share
97%, by CD-marker analysis
Viability
98%, independent laboratory testing
Why this system
From the patient's own blood
EXOMAS prepares autologous platelet derived exosome rich plasma, drawn and processed from the patient's own blood.
No allergic reaction, as D-MED states it
D-MED states that as an autologous system derived entirely from the patient's own blood, EXOMAS removes the risk of an allergic reaction after injection.
A patented tube, developed with physicians
The kit's core processing tube, the D-MED Next-Generation PRX Tube, is patented. D-MED's own R&D team developed it working with physicians, specifically to raise vesicle release from blood cells of particular sizes and densities.
Checked against a stated classification standard
D-MED classifies a vesicle as an exosome only if it falls within a size range of 30 to 220 nm, is characterized using the relevant CD markers, and shows high viability, the standard EXOMAS's own reported values are measured against.
What to know
Practice value
- CD63: 99.0%
- CD9: 99.2%
- CD41a: 99.2%
- CD81: 99.1%
- CD61: 97.0%
- CD11b: 0.2%
- CD14: 0.1%
- CD45: 0.0%
Vesicle surface-marker profile, from D-MED's own flow cytometry testing (Beckman Coulter DxFLEX).
What does EXOMAS EXO Kit prepare?
Autologous platelet derived exosome rich plasma, from the patient's own blood.
Is any donor material used?
No. No product in this portfolio uses human donor material of any kind; every regenerative system here is autologous, plant-derived or synthetic.
What does EXOMAS deliver inside its exosomes?
The manufacturer names mRNA among the cargo, describing it as facilitating the transfer of genetic information between cells.
Who makes EXOMAS EXO Kit?
D-MED, founded under the leadership of Timur Veysel Doğruok to bring a new vision to the field of regenerative medicine.
DNA Nexus support
DNA Nexus supplies EXOMAS EXO Kit as part of the D-MED regenerative range, with after-sales technical support from Cairo.
EXOMAS EXO Kit - D-MED